These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15349011)

  • 21. Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors.
    Schmitt JA; Kruizinga MJ; Riedel WJ
    J Psychopharmacol; 2001 Sep; 15(3):173-9. PubMed ID: 11565624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Pérez V; Soler J; Puigdemont D; Alvarez E; Artigas F
    Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paroxetine: a selective serotonin reuptake inhibiting antidepressant.
    Caley CF; Weber SS
    Ann Pharmacother; 1993 Oct; 27(10):1212-22. PubMed ID: 8251692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers.
    Furlan PM; Kallan MJ; Ten Have T; Pollock BG; Katz I; Lucki I
    Am J Geriatr Psychiatry; 2001; 9(4):429-38. PubMed ID: 11739070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the neuropharmacodynamics of paroxetine in vivo utilizing microdialysis.
    Ramaiya A; Johnson JH; Karnes HT
    J Pharm Sci; 1997 Dec; 86(12):1497-500. PubMed ID: 9423168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paroxetine does not affect the cardiac safety and pharmacokinetics of terfenadine in healthy adult men.
    Martin DE; Zussman BD; Everitt DE; Benincosa LJ; Etheredge RC; Jorkasky DK
    J Clin Psychopharmacol; 1997 Dec; 17(6):451-9. PubMed ID: 9408807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conventional and spectral power analysis of all-night sleep EEG after subchronic treatment with paroxetine in healthy male volunteers.
    Schlösser R; Röschke J; Rossbach W; Benkert O
    Eur Neuropsychopharmacol; 1998 Dec; 8(4):273-8. PubMed ID: 9928916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?
    Johnson BA; Javors MA; Roache JD; Seneviratne C; Bergeson SE; Ait-Daoud N; Dawes MA; Ma JZ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):209-16. PubMed ID: 17950969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial.
    Sharpley AL; Williamson DJ; Attenburrow ME; Pearson G; Sargent P; Cowen PJ
    Psychopharmacology (Berl); 1996 Jul; 126(1):50-4. PubMed ID: 8853216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers.
    Saruwatari J; Yasui-Furukori N; Niioka T; Akamine Y; Takashima A; Kaneko S; Uno T
    J Clin Psychopharmacol; 2012 Apr; 32(2):195-9. PubMed ID: 22367658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 1999 Sep; 48(3):345-54. PubMed ID: 10510145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paroxetine controlled-release formulation in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled study in Japan and Korea.
    Higuchi T; Hong JP; Jung HY; Watanabe Y; Kunitomi T; Kamijima K
    Psychiatry Clin Neurosci; 2011 Dec; 65(7):655-63. PubMed ID: 21895859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paroxetine inhibits acute effects of 3,4-methylenedioxymethamphetamine on the immune system in humans.
    Pacifici R; Pichini S; Zuccaro P; Farré M; Segura M; Ortuño J; Di Carlo S; Bacosi A; Roset PN; Segura J; de la Torre R
    J Pharmacol Exp Ther; 2004 Apr; 309(1):285-92. PubMed ID: 14722327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6.
    Lam YW; Gaedigk A; Ereshefsky L; Alfaro CL; Simpson J
    Pharmacotherapy; 2002 Aug; 22(8):1001-6. PubMed ID: 12173784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone.
    Waldinger MD; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 2001 Jun; 21(3):293-7. PubMed ID: 11386492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
    Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
    Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique.
    Bordet R; Thomas P; Dupuis B
    Am J Psychiatry; 1998 Oct; 155(10):1346-51. PubMed ID: 9766765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers.
    Bell C; Wilson S; Rich A; Bailey J; Nutt D
    Psychopharmacology (Berl); 2003 Mar; 166(2):102-10. PubMed ID: 12536263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SSRIs and ejaculation: a double-blind, randomized, fixed-dose study with paroxetine and citalopram.
    Waldinger MD; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 2001 Dec; 21(6):556-60. PubMed ID: 11763001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of paroxetine on the pharmacokinetics and pharmacodynamics of immediate-release and extended-release metoprolol.
    Parker RB; Soberman JE
    Pharmacotherapy; 2011 Jul; 31(7):630-41. PubMed ID: 21923449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.